Acupuncture for Prevention of Primary Headaches in Children and Adolescents: A Literature Overview for the Pediatric Neurologist

Raffagnato et al. · Pediatric Neurology · 2025

📖Critical Literature Review👥n=229 children/adolescentsLimited but Promising Evidence

Evidence Level

MODERATE
65/ 100
Quality
3/5
Sample
2/5
Replication
2/5
🎯

OBJECTIVE

To evaluate the efficacy of acupuncture in preventing primary headaches in children and adolescents

👥

WHO

Children and adolescents 0-21 years old with migraine and tension-type headache

⏱️

DURATION

Review of studies from 1982-2023

📍

POINTS

TCM-based points: Large Intestine, Stomach, San Jiao, Gallbladder, Du Mai

🔬 Study Design

229participants
randomization

True acupuncture

n=22

Acupuncture or laser acupuncture

Placebo

n=21

Sham acupuncture or laser placebo

Case series

n=186

Observational studies

⏱️ Duration: 4-10 weeks of treatment

📊 Results in numbers

7-8 days/month

Reduction in attack frequency

5.4 points on VAS

Reduction in pain intensity

0%

Positive perception of treatment

P<0.019

Reduction in anxiety

Percentage highlights

67%
Positive perception of treatment

📊 Outcome Comparison

Headache frequency (days/month)

Acupuncture
1.4
Placebo
9.3

Pain intensity (VAS 0-10)

Acupuncture
3.3
Placebo
6.2
💬 What does this mean for you?

This review shows that acupuncture can be a safe and effective option for preventing headaches in children and adolescents. The few available studies indicate that it can significantly reduce attack frequency and intensity, with good tolerability and positive perception by young patients.

📝

Article summary

Plain-language narrative summary

Headache is the most common neurological symptom among children and adolescents, affecting an increasing number of young people as they age. When attacks are intense and frequent, this condition can become truly disabling at any stage of life. Beyond the immediate suffering, excessive use of medications for symptom relief, inadequate treatment of migraine attacks, and other complex factors can cause headache to become chronic. For this reason, about one third of children with headache require preventive treatments to reduce attack frequency, intensity, and duration, avoid overuse of acute medications, and improve quality of life by reducing the disability caused by recurrent pain.

Although recent migraine prevention guidelines support the use of pharmacological and nonpharmacological therapies, an important study called CHAMP showed no significant differences in reduction of headache frequency among children treated with medications such as amitriptyline and topiramate compared with placebo. This has led to growing interest in the use of complementary and alternative medicine for pediatric pain management, including acupuncture. Although adult studies show promising results of acupuncture in headache prevention, data in children and adolescents are very limited.

The objective of this study was to perform a critical review of the scientific literature to better understand the role of acupuncture as preventive treatment for primary headaches in children and adolescents. The investigators sought to evaluate whether acupuncture is more effective than sham acupuncture or pharmacological preventive treatment, and to examine the tolerability of treatment and its possible benefits on psychiatric comorbidities such as anxiety and depression. To do so, they conducted a systematic review following rigorous scientific guidelines, analyzing all studies published between 1982 and 2023 that investigated the preventive use of acupuncture in primary headaches in young patients up to age 21.

Of the 90 studies initially identified, only five met the inclusion criteria, totaling 229 children and adolescents. Among these studies, two were controlled trials specifically evaluating reduction in headache frequency, intensity, and duration. Results were encouraging: true acupuncture proved significantly more effective than placebo in reducing headache frequency, with a decrease of seven to eight headache days per month in the true acupuncture group, compared with a reduction of only zero to one day in the placebo group. In addition, there was a significant reduction in pain intensity, measured on a 0-to-10 visual analog scale, with a decrease of 5.4 points in the true acupuncture group compared with only 1.6 points in the placebo group.

Attack duration was also significantly reduced.

The clinical implications of these findings are particularly relevant for families seeking alternatives to traditional pharmacological treatments or for cases in which conventional medications have not provided adequate relief. Studies showed that acupuncture had favorable tolerability, with no adverse events reported in most analyzed work. This is especially important when considering the side-effect profile some preventive medications can have in children and adolescents. The acupuncture experience was perceived positively by most patients participating in the studies, suggesting good acceptance of treatment in this age group.

In addition to direct benefits in reducing headache symptoms, some studies showed improvements in pain-related interference with the children's general functioning, including physical, social, and school activities. There was also a reduction in anxiety levels, although depressive symptoms did not change significantly. These findings are particularly relevant because chronic headaches in children frequently impact not only physical well-being but also social and academic development.

For clinicians, these results suggest that acupuncture can be considered a valid therapeutic option in the preventive treatment armamentarium for primary headaches in children and adolescents. The possibility of offering an effective nonpharmacological alternative is especially valuable in pediatrics, where minimizing medications is always desirable. In addition, the fact that acupuncture showed benefits in general functioning and anxiety suggests a potential holistic effect of the treatment.

However, it is important to recognize the significant limitations of this review. The small number of available studies and the heterogeneity of the studied populations represent important obstacles to drawing definitive conclusions. The age range of participants varied considerably, and not all studies were specifically focused on pediatric headaches. In addition, post-treatment follow-up was relatively short in most studies, making it difficult to assess whether the benefits are maintained over time.

The methodological quality of the studies also varied, with only one of the main studies receiving a high score on scientific quality criteria.

Although the few available studies on acupuncture as preventive treatment for pediatric primary headaches highlight its potential efficacy, despite their methodological limitations, more detailed and rigorously conducted studies are needed to definitively establish the role of this therapy. For families considering this option, it is important to discuss with qualified clinicians both the potential benefits and the limitations of the current evidence, ensuring that the decision is made in an informed and individualized way for each child.

Strengths

  • 1Significant reduction in headache frequency and intensity
  • 2Good tolerability with no significant adverse events
  • 3Positive perception by pediatric patients
  • 4Reduction in anxiety and improvement in general functioning
⚠️

Limitations

  • 1Only 5 included studies with small samples
  • 2Methodological heterogeneity across studies
  • 3Lack of comparison with pharmacological preventive treatments
  • 4Short-term follow-up in most studies
Dr. Marcus Yu Bin Pai

Expert Commentary

Dr. Marcus Yu Bin Pai

MD, PhD · Pain Medicine · Physical Medicine and Rehabilitation · Medical Acupuncture

Clinical Relevance

Primary headache in children and adolescents represents a real therapeutic challenge, and the data from the CHAMP trial — which showed no superiority of amitriptyline or topiramate over placebo in this population — places clinicians in front of a pharmacological vacuum that needs to be filled. This review fills part of that space by documenting that acupuncture surpasses placebo both in frequency (reduction of seven to eight headache days per month versus zero to one day in the control group) and in attack intensity (5.4-point drop on the VAS). For the physiatrist and the pediatric neurologist, this opens a concrete therapeutic window: patients with high-frequency migraine who do not tolerate or do not respond to available pharmacological preventive options are natural candidates for this approach. The absence of significant adverse events reinforces the safety of the method in this age group.

Notable Findings

The clinically most important finding is the magnitude of difference between true and sham acupuncture in attack frequency: seven to eight fewer headache days per month is a result that exceeds, in practical relevance, what we usually see with several preventive drugs in adults. Equally notable is the 5.4-point reduction on the VAS for intensity, a difference that surpasses any commonly accepted threshold for minimal clinically important difference. The data on anxiety (P < 0.019) deserves special attention because psychiatric comorbidity is a well-established factor for chronification in pediatric headaches — treating pain and anxiety simultaneously with a single intervention has strategic value. The positive perception of treatment in 67% of patients is also relevant for adherence, especially in adolescents.

From My Experience

In my practice with musculoskeletal pain and headache, I have progressively been receiving more children and adolescents referred from pediatric neurology after pharmacological failure or intolerance. The pattern I observe is a perceptible initial response between the third and fifth session — parents usually report a reduction in attack frequency even before the patient verbalizes improvement in intensity. I usually work with cycles of eight to twelve sessions at weekly frequency, with reassessment at the end to decide on spacing or discharge. I systematically combine treatment with sleep hygiene guidance and stress management, which in this age group are frequently determining cofactors. The profile that responds best, in my experience, is the adolescent with migraine without aura of moderate to high frequency, especially when there is an associated anxiety component. I avoid the indication in children below six or seven years old due to the difficulty of cooperation during the procedure, except in very specific contexts with laser acupuncture.

PhD in Health Sciences, University of São Paulo. Board-certified in Pain Medicine, Physical Medicine and Rehabilitation, and Medical Acupuncture.

Full original article

Read the full scientific study

Pediatric Neurology · 2025

DOI: 10.1016/j.pediatrneurol.2024.12.013

Access original article

Scientific Review

Marcus Yu Bin Pai, MD, PhD

Marcus Yu Bin Pai, MD, PhD

CRM-SP: 158074 | RQE: 65523 · 65524 · 655241

PhD in Health Sciences, University of São Paulo. Board-certified in Pain Medicine, Physical Medicine and Rehabilitation, and Medical Acupuncture. Scientific review and curation of every entry in this library.

Learn more about the author →
⚕️

Medical disclaimer: This content is for educational purposes only and does not replace consultation, diagnosis, or treatment by a qualified professional. Some information may be assisted by artificial intelligence and is subject to inaccuracies. Always consult a physician.

Content reviewed by the medical team at CEIMEC — Integrated Centre for Chinese Medicine Studies, a reference in Medical Acupuncture for over 30 years.